China Slashes Its Growth Target to a 30-Year Low: Buy, Hold or Sell ASX Mining Stocks?

Ujjwal Maheshwari Ujjwal Maheshwari, March 17, 2026

ASX mining stocks slide as China slows

ASX mining stocks are under serious pressure. Copper fell 2.4% overnight to US$5.70 per pound, nickel dropped 2.7% to US$17,250 per tonne, and aluminium shed 2.5%, dragging the Materials Index sharply lower. The trigger is not one piece of news but a building picture. At China’s annual Two Sessions on March 5, Premier Li Qiang formally set Beijing’s 2026 GDP growth target at 4.5 to 5%, the least ambitious goal since the early 1990s. Full-year 2025 data then confirmed fixed asset investment contracted 3.8% and property investment collapsed 17.2%. For investors holding BHP, Fortescue, and Sandfire, one question matters right now: Is this pain worth buying into, or a signal to step back?

What are the Best ASX Mining Stocks to invest in right now?

Check our buy/sell tips

What China’s Numbers Actually Say and Why They Matter

Think of China’s economy as the engine that powers global commodity demand. When that engine slows, Australian miners feel it almost immediately.

The engine is clearly sputtering. Chinese retail sales slowed to just 0.9% growth in December 2025, near their weakest pace outside the COVID era. While today’s January to February 2026 data showed a partial rebound to 2.8%, driven largely by the Lunar New Year holiday, analysts cautioned that underlying consumer confidence remains soft and the bounce may not hold.

The bigger concern, in our view, is what is happening in property. Chinese real estate investment fell 17.2% across 2025 and is still falling into 2026. This matters because construction is the single biggest driver of steel demand in China. When fewer buildings go up, steel mills produce less, which means they need less iron ore, and that is exactly where most ASX miners earn their money.

What makes this more than a typical slowdown is Beijing’s own framing. At the Two Sessions, policymakers made clear this target reflects a deliberate pivot toward what they call high-quality growth, prioritising AI, green technology, and semiconductors over the old model of building and construction. For iron ore-heavy names, that framing is critical. It tells investors the drop in construction-driven steel demand is not a temporary weakness. It is deliberate policy.

Which ASX Mining Stocks Are Most at Risk

Not all miners face the same level of pain here, and understanding the difference matters.

Fortescue (ASX: FMG) is the most exposed of the majors. Its business is almost entirely built around selling iron ore to Chinese steel mills. If construction stays weak by design, the demand side of that equation gets structurally difficult. BHP (ASX: BHP) and Rio Tinto (ASX: RIO) carry similar iron ore risk, though their more diversified operations offer some buffer that Fortescue simply does not have.

Copper names like Sandfire Resources (ASX: SFR) and South32 (ASX: S32) sit in a better position. Yes, copper fell overnight, but its long-term demand story, driven by data centres, electricity grids, and electric vehicles, aligns closely with exactly what Beijing is now prioritising. A short-term selloff in these names is worth watching closely.

The Investor’s Takeaway

We think investors need to be selective rather than broad-brush here.

The case for buying the dip is real for copper stocks. If broader China anxiety drags Sandfire and South32 lower in the near term, we believe that could be a genuine opportunity for investors thinking 12 to 24 months ahead.

For pure iron ore plays like Fortescue, we would urge patience. China’s property downturn looks structural, not a short-term blip, and Beijing is actively steering investment away from the sectors that drive iron ore demand.

The key signal to watch is China’s monthly steel production data. A genuine recovery there would change our thinking quickly. Until then, a cautious approach to iron ore and a more opportunistic eye on copper is where we stand.

Blog Categories

Get the Latest Insider Trades on ASX!

Recent Posts

T-Cell Lymphoma is a very deadly cancer, but this ASX stock has a treatment in a Phase 2 trial!

  Prescient Therapeutics‘ (ASX:PTX) trial of PTX-100 against T-Cell Lymphoma is well and truly underway now with 8 out of…

How Emerging Technologies Are Creating New Investment Opportunities

The Australian share market has long been defined by its “rocks and stocks” reputation, heavily weighted towards mining giants and…

Amcor (ASX:AMC): This Packaging Giant Is Under Pressure, But Is the Yield Worth the Wait?

Amcor (ASX:AMC) is celebrating its 100th anniversary later this year, but it would seem there’s little else to celebrate right…